Page last updated: 2024-09-05

lapatinib and Left Ventricular Outflow Obstruction

lapatinib has been researched along with Left Ventricular Outflow Obstruction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bedard, PL; de Azambuja, E; Piccart-Gebhart, M; Suter, T	1

Reviews

1 review(s) available for lapatinib and Left Ventricular Outflow Obstruction

Article	Year
Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? Targeted oncology, 2009, Volume: 4, Issue:2 Topics: Adjuvants, Immunologic; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Heart Failure; Humans; Lapatinib; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Survival Rate; Trastuzumab; Ventricular Outflow Obstruction	2009

Article

Year

Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?

Targeted oncology, 2009, Volume: 4, Issue:2

Topics: Adjuvants, Immunologic; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Heart Failure; Humans; Lapatinib; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Survival Rate; Trastuzumab; Ventricular Outflow Obstruction

2009